News Third fire at Novo Nordisk, but company says there’s no link Danish drugmaker Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.
News Second fire at Novo Nordisk in a week now under control Firefighters have been able to extinguish a fire that raged through an office building at the site of Novo Nordisk’s headquarters in Denmark, although it will not survive
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.